Stock listing

OTC:GNBT Generex Biotechnology Corp Stock

Follow Generex Biotechnology Corp into a list and get an email when it puts out news.

Delisted OTC:GNBT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
OTC:GNBT
Asset type
Stock
Exchange
OTC
Currency
USD

Generex Biotechnology Corp on 6ix

Decks
1 deck · latest Dec 4, 2018

Decks

DeckKindSlidesDate
Investor Presentation (December 2018)Investor deck17 slidesDec 4, 2018

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Mark Corrao
Other companies: Apimeds Pharmaceuticals US, Inc. (Chief Financial Officer · Mar 4, 2025 – Mar 4, 2025 · Past); Amesite Inc. (Chief Financial Officer · Dec 15, 2021 – Dec 15, 2021 · Past); Neuropathix Inc (Chief Financial Officer · Mar 12, 2021 – Mar 12, 2021 · Past); Brain Scientific, Inc. (Chief Financial Officer · Oct 15, 2020 – Oct 15, 2020 · Past); Western Graphite Inc (CFO and Secretary, Director · Apr 1, 2015 – Apr 1, 2015 · Past)
CFO & Treasurer · Oct 3, 2018 – Oct 15, 2018 · Past
Richard David Purcell Jr
Other companies: RespireRx Pharmaceuticals Inc (SVP - Research and Development · Mar 31, 2016 – Jul 31, 2020 · Past)
SVP Product Launch & Develop · Oct 3, 2018 – Oct 15, 2018 · Past
Andrew RoChief Investment Officer & SVP, Director · Oct 3, 2018 – Oct 15, 2018 · Past
Gary Herbert LymanDirector · Oct 3, 2018 – Oct 15, 2018 · Past
James H Anderson JrDirector · Jun 8, 2011 – Oct 3, 2018 · Past
Mark FletcherEVP General Counsel &Secretary · Aug 17, 2007 – Oct 3, 2018 · Past
Mark Joseph SE PriolettiDirector · Jun 27, 2019 – Jun 27, 2019 · Past
Peter AmanatidesDirector · May 30, 2006 – May 30, 2006 · Past

Open People

Log in to ask 6ix AI your own questions about Generex Biotechnology Corp.